Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 04:15:08 UTC |
---|
Update Date | 2022-03-07 02:49:19 UTC |
---|
HMDB ID | HMDB0003747 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Resveratrol |
---|
Description | Resveratrol is a polyphenolic phytoalexin. It is also classified as a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. The levels of resveratrol found in food vary greatly. Red wine contains between 0.2 and 5.8 mg/L depending on the grape variety, while white wine has much less. The reason for this difference is that red wine is fermented with grape skins, allowing the wine to absorb the resveratrol, whereas white wine is fermented after the skin has been removed. Resveratrol is also sold as a nutritional supplement. A number of beneficial health effects, such as anti-cancer, antiviral, neuroprotective, anti-aging, anti-inflammatory, and life-prolonging effects have been reported for resveratrol. The fact that resveratrol is found in the skin of red grapes and as a constituent of red wine may explain the "French paradox". This paradox is based on the observation that the incidence of coronary heart disease is relatively low in southern France despite high dietary intake of saturated fats. Resveratrol is thought to achieve these cardioprotective effects by a number of different routes: (1) inhibition of vascular cell adhesion molecule expression; (2) inhibition of vascular smooth muscle cell proliferation; (3) stimulation of endothelial nitric oxide synthase (eNOS) activity; (4) inhibition of platelet aggregation; and (5) inhibition of LDL peroxidation (PMID: 17875315 , 14676260 , 9678525 ). Resveratrol is a biomarker for the consumption of grapes and raisins. |
---|
Structure | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
---|
Synonyms | Value | Source |
---|
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol | ChEBI | (e)-Resveratrol | ChEBI | 3,4',5-Stilbenetriol | ChEBI | 3,4',5-Trihydroxy-trans-stilbene | ChEBI | 3,4',5-Trihydroxystilbene | ChEBI | 3,5,4'-Trihydroxystilbene | ChEBI | 5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol | ChEBI | trans-Resveratrol | Kegg | SRT-501 | MeSH | trans Resveratrol | MeSH | SRT 501 | MeSH | trans-3,4',5 - Trihydroxystilbene | HMDB | (E)-2-(3,5-Dihydroxyphenyl)-1-(4-hydroxyphenyl)ethene | HMDB | (E)-3,4',5-Trihydroxystilbene | HMDB | (E)-3,4’,5-Trihydroxystilbene | HMDB | (E)-5-(p-Hydroxystyryl)resorcinol | HMDB | 3,4’,5-Stilbenetriol | HMDB | 3,4’,5-Trihydroxy-trans-stilbene | HMDB | 3,4’,5-Trihydroxystilbene | HMDB | 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol | HMDB | Resveratrol | HMDB | trans-3,5,4'-Trihydroxystilbene | HMDB | trans-3,5,4’-Trihydroxystilbene | HMDB | (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol | PhytoBank |
|
---|
Chemical Formula | C14H12O3 |
---|
Average Molecular Weight | 228.247 |
---|
Monoisotopic Molecular Weight | 228.078644246 |
---|
IUPAC Name | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
---|
Traditional Name | resveratrol |
---|
CAS Registry Number | 501-36-0 |
---|
SMILES | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
---|
InChI Key | LUKBXSAWLPMMSZ-OWOJBTEDSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Stilbenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Stilbenes |
---|
Alternative Parents | |
---|
Substituents | - Stilbene
- Styrene
- Resorcinol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Benzenoid
- Monocyclic benzene moiety
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Resveratrol,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O)=CC(O)=C2)C=C1 | 2651.0 | Semi standard non polar | 33892256 | Resveratrol,1TMS,isomer #2 | C[Si](C)(C)OC1=CC(O)=CC(/C=C/C2=CC=C(O)C=C2)=C1 | 2621.9 | Semi standard non polar | 33892256 | Resveratrol,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O)=CC(O[Si](C)(C)C)=C2)C=C1 | 2614.2 | Semi standard non polar | 33892256 | Resveratrol,2TMS,isomer #2 | C[Si](C)(C)OC1=CC(/C=C/C2=CC=C(O)C=C2)=CC(O[Si](C)(C)C)=C1 | 2636.0 | Semi standard non polar | 33892256 | Resveratrol,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C2)C=C1 | 2624.5 | Semi standard non polar | 33892256 | Resveratrol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O)=CC(O)=C2)C=C1 | 2920.3 | Semi standard non polar | 33892256 | Resveratrol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC(O)=CC(/C=C/C2=CC=C(O)C=C2)=C1 | 2907.3 | Semi standard non polar | 33892256 | Resveratrol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3165.3 | Semi standard non polar | 33892256 | Resveratrol,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC(/C=C/C2=CC=C(O)C=C2)=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3145.5 | Semi standard non polar | 33892256 | Resveratrol,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(/C=C/C2=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3396.3 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Resveratrol GC-MS (3 TMS) | splash10-0006-1853900000-4919511a11ec24935434 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Resveratrol GC-MS (Non-derivatized) | splash10-0006-1853900000-4919511a11ec24935434 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Resveratrol GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-0790000000-615dafbde185688e8755 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Resveratrol GC-MS (3 TMS) - 70eV, Positive | splash10-00fr-8009800000-8b40ad68f231308861d4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Resveratrol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF , Negative-QTOF | splash10-004i-0090000000-f9ff90d98488d6d05587 | 2017-08-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 50V, Negative-QTOF | splash10-004i-0090000000-f9ff90d98488d6d05587 | 2017-08-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 60V, Negative-QTOF | splash10-004i-0090000000-f9ff90d98488d6d05587 | 2017-08-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 20V, Negative-QTOF | splash10-004i-0590000000-4a9b53d6aad6ed8189d2 | 2017-08-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 40V, Negative-QTOF | splash10-004i-0590000000-4a9b53d6aad6ed8189d2 | 2017-08-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF , Negative-QTOF | splash10-004i-0090000000-f9ff90d98488d6d05587 | 2017-09-12 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 50V, Negative-QTOF | splash10-014i-0900000000-79bf3bfcbb7bcdd0ffd2 | 2017-09-12 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 60V, Negative-QTOF | splash10-014i-0900000000-9340e3fe04d435cf8475 | 2017-09-12 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 20V, Negative-QTOF | splash10-004i-0590000000-4a9b53d6aad6ed8189d2 | 2017-09-12 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol ESI-TOF 40V, Negative-QTOF | splash10-00kf-0900000000-b0f6bf3388d96335d77e | 2017-09-12 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-qTof , Positive-QTOF | splash10-004i-1890000000-5a90c0c5508894cb16af | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-qTof , Positive-QTOF | splash10-014i-2910000000-e0183692948660939c19 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QTOF , negative-QTOF | splash10-004i-0090000000-d9def7cee71fb7a40786 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QTOF , negative-QTOF | splash10-004r-0970000000-f8c7ca07f27bfc1b8bda | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QTOF , negative-QTOF | splash10-0006-0900000000-b1333b06db343c38f529 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QTOF , negative-QTOF | splash10-014l-0900000000-c856c7fa9653868e5785 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QQ , negative-QTOF | splash10-004r-0950000000-8e44b9aa58ac75282058 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-QQ , negative-QTOF | splash10-000f-0900000000-2b750fcfd933ce8809f2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Resveratrol LC-ESI-TOF , negative-QTOF | splash10-014i-0900000000-79bf3bfcbb7bcdd0ffd2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 10V, Positive-QTOF | splash10-004i-0090000000-655581acb694e423a693 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 20V, Positive-QTOF | splash10-004i-0690000000-37f13318e23ebae81b00 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 40V, Positive-QTOF | splash10-014u-3910000000-e87807281eb836a65eb0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 10V, Negative-QTOF | splash10-004i-0090000000-0d55e176d88ed31cd1cd | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 20V, Negative-QTOF | splash10-004i-0190000000-cfdf20e77b23e0cc49e2 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Resveratrol 40V, Negative-QTOF | splash10-0a73-3930000000-243d9e319d0fee123dee | 2016-08-04 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Brain
- Epidermis
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Pancreas
- Placenta
- Platelet
- Prostate
- Skeletal Muscle
- Spleen
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Consuming polyphenols described by Phenol-Explorer entry 592 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Consuming polyphenols described by Phenol-Explorer entry 592 | | details | Urine | Detected and Quantified | 0.006 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0156 +/- 0.0280 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB02709 |
---|
Phenol Explorer Compound ID | 592 |
---|
FooDB ID | FDB002451 |
---|
KNApSAcK ID | C00002903 |
---|
Chemspider ID | 392875 |
---|
KEGG Compound ID | C03582 |
---|
BioCyc ID | CPD-83 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Resveratrol |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 445154 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 45713 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1588831 |
---|
References |
---|
Synthesis Reference | Chen, Xin; Mei, Yicheng; Yu, Aimin; Wang, Kaiwen. Improved method for preparation of resveratrol. Faming Zhuanli Shenqing Gongkai Shuomingshu (2007), 6pp. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO: Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. J Nutr. 2006 Oct;136(10):2542-6. [PubMed:16988123 ]
- Olas B, Zbikowska HM, Wachowicz B, Krajewski T, Buczynski A, Magnuszewska A: Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol. 1999;46(4):961-6. [PubMed:10824865 ]
- Vilar S, Quezada E, Santana L, Uriarte E, Yanez M, Fraiz N, Alcaide C, Cano E, Orallo F: Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg Med Chem Lett. 2006 Jan 15;16(2):257-61. Epub 2005 Nov 3. [PubMed:16275073 ]
- Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004 Sep-Oct;24(5A):2783-840. [PubMed:15517885 ]
- Olas B, Nowak P, Wachowicz B: Resveratrol protects against peroxynitrite-induced thiol oxidation in blood platelets. Cell Mol Biol Lett. 2004;9(4A):577-87. [PubMed:15647782 ]
- Kirk RI, Deitch JA, Wu JM, Lerea KM: Resveratrol decreases early signaling events in washed platelets but has little effect on platelet in whole blood. Blood Cells Mol Dis. 2000 Apr;26(2):144-50. [PubMed:11001623 ]
- Olas B, Wachowicz B, Majsterek I, Blasiak J: Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anticancer Drugs. 2005 Jul;16(6):659-65. [PubMed:15930895 ]
- Anekonda TS: Resveratrol--a boon for treating Alzheimer's disease? Brain Res Rev. 2006 Sep;52(2):316-26. [PubMed:16766037 ]
- Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, Jaeger W: Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica. 2005 Dec;35(12):1101-19. [PubMed:16418064 ]
- Chun YJ, Kim MY, Guengerich FP: Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun. 1999 Aug 19;262(1):20-4. [PubMed:10448061 ]
- Gester S, Wuest F, Pawelke B, Bergmann R, Pietzsch J: Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography. Amino Acids. 2005 Dec;29(4):415-28. Epub 2005 Jul 8. [PubMed:15997411 ]
- Fulda S, Debatin KM: Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 2004 Jan 1;64(1):337-46. [PubMed:14729643 ]
- Kimura Y, Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr. 2001 Jun;131(6):1844-9. [PubMed:11385077 ]
- Gehm BD, McAndrews JM, Chien PY, Jameson JL: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14138-43. [PubMed:9391166 ]
- Bertelli AA, Giovannini L, Bernini W, Migliori M, Fregoni M, Bavaresco L, Bertelli A: Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res. 1996;22(2):61-3. [PubMed:8998912 ]
- Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N, Solary E: Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem. 2003 Oct 17;278(42):41482-90. Epub 2003 Aug 5. [PubMed:12902349 ]
- Yanez M, Fraiz N, Cano E, Orallo F: Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun. 2006 Jun 2;344(2):688-95. Epub 2006 Apr 17. [PubMed:16631124 ]
- Lee B, Moon SK: Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr. 2005 Dec;135(12):2767-73. [PubMed:16317118 ]
- Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther. 2006 May;5(5):1335-41. [PubMed:16731767 ]
- Zhuang H, Kim YS, Koehler RC, Dore S: Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci. 2003 May;993:276-86; discussion 287-8. [PubMed:12853318 ]
- Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L: Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev. 2007 Oct;128(10):546-52. Epub 2007 Aug 14. [PubMed:17875315 ]
- Ferrieres J: The French paradox: lessons for other countries. Heart. 2004 Jan;90(1):107-11. [PubMed:14676260 ]
- Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol. 1998 Jun;138(6):619-20. [PubMed:9678525 ]
|
---|